Evidence map›Paper›PMID 35621869›Full record

ReviewJournal of cardiovascular development and disease2022

Practical Approaches to Build and Sustain a Cardio-Oncology Clinic.

Angeliki Chasouraki, Christos Kourek, Alexandros Sianis, Konstantinos Loritis, Peggy Kostakou, Elias Tsougos, Ioannis Paraskevaidis, Argyrios Ntalianis, Alexandros Briasoulis

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of cardiovascular development and disease, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Cardiovascular Toxicity Related to Cancer Treatment.Journal of cardiovascular development and disease · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 2 countries.

Angeliki ChasourakiDepartment of Clinical Therapeutics, National Kapodestrian University of Athens, 11528 Athens, Greece.ORCID 0000-0003-0288-8173
Christos KourekDepartment of Clinical Therapeutics, National Kapodestrian University of Athens, 11528 Athens, Greece.ORCID 0000-0003-4348-2153
Alexandros SianisDepartment of Clinical Therapeutics, National Kapodestrian University of Athens, 11528 Athens, Greece.
Konstantinos LoritisDepartment of Clinical Therapeutics, National Kapodestrian University of Athens, 11528 Athens, Greece.
Peggy KostakouDepartment of Clinical Therapeutics, National Kapodestrian University of Athens, 11528 Athens, Greece.ORCID 0000-0002-3821-224X
Elias TsougosDepartment of Clinical Therapeutics, National Kapodestrian University of Athens, 11528 Athens, Greece.
Ioannis ParaskevaidisDepartment of Clinical Therapeutics, National Kapodestrian University of Athens, 11528 Athens, Greece.
Argyrios NtalianisDepartment of Clinical Therapeutics, National Kapodestrian University of Athens, 11528 Athens, Greece.
Alexandros BriasoulisDepartment of Clinical Therapeutics, National Kapodestrian University of Athens, 11528 Athens, Greece.ORCID 0000-0002-5740-9670
National and Kapodistrian University of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The therapeutical advances in recent years in the field of oncology treatment have increased survival rates and improved the quality of life of oncology patients, thus turning cancer into a chronic disease. However, most of the new cancer treatments come at the expense of serious cardiovascular adverse events threatening the success story of these patients. The establishment of multidisciplinary medical teams to prevent, monitor, and treat cardiovascular diseases in cancer-treated patients is needed now more than ever. The aim of this narrative review is to demonstrate the existing knowledge and practical approaches on how to establish and maintain a cardio-oncology program for the rising number of patients who need it.

Indexed as

cardio-oncologycardiotoxicitychemotherapyheart failure

Identifiers

PMID35621869
PMCPMC9146440
OpenAlexW4280516532

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.